default author photo

Weidong Han

Zhejiang University - Department of Medical Oncology

Zhejiang

China

Zhejiang University - Laboratory of Cancer Biology

Zhejiang

China

SCHOLARLY PAPERS

6

DOWNLOADS

549

TOTAL CITATIONS

0

Scholarly Papers (6)

1.

Comprehensive Analysis of a circRNA-Mediated Competing Endogenous RNA Network in Pancreatic Adenocarcinoma

Number of pages: 28 Posted: 11 Jun 2019
Zhejiang University - Department of Medical Oncology, Zhejiang Chinese Medical University, Zhejiang Chinese Medical University, Wenzhou Medical University - First Affiliated Hospital, Zhejiang University - Department of Medical Oncology, Zhejiang University - Department of Medical Oncology, Zhejiang University - Department of Medical Oncology, Zhejiang University - Department of Medical Oncology, Zhejiang University - Department of Medical Oncology, Zhejiang Chinese Medical University, Jiaxing University - First Affiliated Hospital, Zhejiang University - Department of Medical Oncology and Zhejiang University - Department of Medical Oncology
Downloads 168 (447,215)

Abstract:

Loading...

pancreatic adenocarcinoma; circRNA; ceRNA; immune microenvironment

2.

Bispecific Chimeric Antigen Receptor Targeting Both CD19 and CD22 T Cell Therapy in Adults with Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia

Number of pages: 28 Posted: 20 Jul 2019
Government of the People's Republic of China - Department of Molecular Biology and Immunology, Government of the People's Republic of China - Department of Molecular Biology and Immunology, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Department of Molecular Biology and Immunology, Government of the People's Republic of China - Department of Molecular Biology and Immunology, Government of the People's Republic of China - Department of Molecular Biology and Immunology, Government of the People's Republic of China - Department of Bio-Therapeutic, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Department of Bio-Therapeutic, Government of the People's Republic of China - Department of Molecular Biology and Immunology and Zhejiang University - Department of Medical Oncology
Downloads 105 (669,616)

Abstract:

Loading...

Bispecific chimeric antigen receptor, B-cell acute lymphoblastic leukemia, Cell therapy

3.

Nivolumab in Combination with Gemcitabine and Cisplatin for Advanced Unresectable or Metastatic Biliary Tract Cancers: Results from a Single Center, Single-Arm, Phase I Study

Number of pages: 77 Posted: 07 Jun 2019
Government of the People's Republic of China - Department of Bio-Therapeutic, Government of the People's Republic of China - Chinese PLA General Hospital, Government of the People's Republic of China - Department of Bio-Therapeutic, Government of the People's Republic of China - Department of Bio-Therapeutic, Government of the People's Republic of China - Department of Molecular Biology and Immunology, Government of the People's Republic of China - Department of Molecular Biology and Immunology, Government of the People's Republic of China - Department of Molecular Biology and Immunology and Zhejiang University - Department of Medical Oncology
Downloads 95 (715,072)

Abstract:

Loading...

Nivolumab; Gemcitabine; advanced unresectable or metastatic biliary tract cancers; PD-1; immune checkpoint inhibitor

4.

Interpretable Artificial Intelligence in Assisting Treatment Response Prediction for Locally Advanced Rectal Cancer: A Prospective, Multicenter, Human-Model Interaction Study

Number of pages: 25 Posted: 02 Jul 2024
Sun Yat-sen University (SYSU), Southern Medical University - Department of Radiology, Sun Yat-sen University (SYSU), Zhejiang Chinese Medical University, Sun Yat-sen University (SYSU), Sun Yat-sen University (SYSU), Sun Yat-sen University (SYSU), Southern Medical University - Guangdong Provincial Key Laboratory of Gastroenterology, Sun Yat-sen University (SYSU), Zhejiang University - Department of Medical Oncology, Zhejiang Chinese Medical University, Guangdong Academy of Medical Sciences - Department of Radiology, Zhengzhou University and affiliation not provided to SSRN
Downloads 84 (777,583)

Abstract:

Loading...

Artificial Intelligence, Radiomics, Interpretable AI-Human Interaction, Machine Learning, Pathological Complete Response, Rectal Cancer

5.

High TRIM59 Expression Predicts Adverse Outcomes and Is Correlated with Immune Infiltrates in Lung Adenocarcinoma

Number of pages: 24 Posted: 19 Nov 2020
Zhejiang University - Department of Respiratory Medicine, Zhejiang University - Department of Respiratory Medicine, Zhejiang University - Department of Medical Oncology, Zhejiang University - Department of Medical Oncology, Zhejiang University - Department of Medical Oncology, Zhejiang University - Department of Medical Oncology and Zhejiang University - Department of Respiratory Medicine
Downloads 57 (989,921)

Abstract:

Loading...

TRIM59, LUAD, TCGA, TIMER, Immune infiltrates, Prognosticator

6.

Cyclosporine A Sensitizes Lung Cancer Cells to Crizotinib Through Inhibition of the Ca2 /Calcineurin/Erk Pathway

Number of pages: 40 Posted: 14 Feb 2019
Zhengzhou University - Department of Neurosurgery, Zhejiang University, Zhejiang University, Zhejiang University - Department of Medical Oncology, Zhejiang University, Zhejiang University, Zhejiang University, Zhejiang University, Zhejiang University - Department of Medical Oncology and Zhejiang University - Department of Medical Oncology
Downloads 40 (1,183,237)

Abstract:

Loading...

Cyclosporine A; Erk1/2; crizotinib; lung cancer; calcium